• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Publication

Article

February 25, 2020

Pharmacy Times

February 2020
Volume87
Issue 2

Study Results Link Postpartum Depression to Inflammation

Author(s):

Aislinn Antrim, Assistant Editor

The results of a recent study published in Brain, Behavior, and Immunity suggest that inflammation and the kynurenine pathway may be connected to postpartum depression (PPD) and therefore may present new treatment targets in severe PPD.

The results of a recent study published in Brain, Behavior, and Immunity suggest that inflammation and the kynurenine pathway may be connected to postpartum depression (PPD) and therefore may present new treatment targets in severe PPD.1

Although PPD is common, with the US Department of Health and Human Services estimating that 1 in 9 new mothers has the condition,2 the researchers said that severe depression with suicidality during pregnancy and postpartum is an understated disorder.1

Previous studies have suggested that the condition may be triggered by dynamic changes of the immune system during and after pregnancy. The cross-sectional study aimed to establish whether a pro-inflammatory status in plasma, combined with changes in the kynurenine pathway activity, is associated with the development of severe PPD and suicidal behavior.1

The kynurenine pathway is the primary route for tryptophan catabolism in the liver. Dysregulation or overactivation of the pathway has been associated with immune system activation and accumulation of potentially neurotoxic compounds.3

The researchers analyzed plasma IL-1β, IL-2, IL-6, IL-8, TNF-α, tryptophan, serotonin, kynurenine, nicotinamide, and quinolinic- and kynurenic acids in postpartum women diagnosed with peripartum-onset depression.1

They found that increased plasma IL-6 and IL-8, when combined with reductions of IL-2, quinolinic acid, and serotonin was associated with the severity of depressive symptoms and increased the risk for PPD.1 Furthermore, women with lower serotonin levels had an increased risk for suicidal behavior, even when adjusting for age, body mass index, depression severity, medication, and psychosocial factors.1

These findings suggest that severe PPD is linked with dysregulation of the immune response and the kynurenine pathway, with a concomitant reduction in serotonin levels. The researchers concluded that this finding may present the possibility of novel therapeutic strategies targeting women during pregnancy.1

REFERENCES

  • Achtyes E, Keaton S, Smart L, et al. Inflammation and kynurenine pathway dysregulation in post-partum women with severe and suicidal depression. Brain Behav Immun. 2020;83:239-247. doi: 10.1016/j.bbi.2019.10.017.
  • US Department of Health and Human Services. Postpartum depression. Office on Women’s Health website. womenshealth.gov/mental-health/mental-health-conditions/postpartum-depression. Updated May 14, 2019. Accessed Dec 2, 2019.
  • Davis I, Liu A. What is the tryptophan kynurenine pathway and why is it important to neurotherapy? Expert Rev Neurother. 2015;15(7):719-721.

Articles in this issue

Interactives: Case Studies (February 2020)
Interactives: Case Studies (February 2020)
Clinical Pharmacology Update: Xenleta from Nabriva Therapeutics
Clinical Pharmacology Update: Xenleta from Nabriva Therapeutics
Can a Patient with HIV Maintain a Lawsuit?
Can a Patient with HIV Maintain a Lawsuit?
Help Teens Who Struggle With Depression
Help Teens Who Struggle With Depression
Study Results Link Postpartum Depression to Inflammation
Study Results Link Postpartum Depression to Inflammation
Clinical Evidence Exists for Allopregnanolone-based Treatments
Clinical Evidence Exists for Allopregnanolone-based Treatments

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Practice Pearl #1 Active Surveillance vs Treatment in Patients with NETs
Related Content
Advertisement
Pharmacist Spotlight: David Newman, BSPharm, RPh
August 29th 2025

Pharmacist Spotlight: David Newman, BSPharm, RPh

PT Staff David Newman, BSPharm, RPh
High-quality image of prescription opioids bottle on table symbolizing addiction crisis. Concept Addiction Crisis, Prescription Opioids, Substance Abuse, Drug Addiction Awareness - Image credit: Anastasiia | stock.adobe.com
August 29th 2025

Condition Watch: Opioid Use Disorder

Alexandra Gerlach, Associate Editor Danielle Valletti, Assistant Editor
Image credit: IbragimovN | stock.adobe.com
August 29th 2025

Products News for August 2025

Danielle Valletti, Assistant Editor
Culturally Tailored Education Empowers Patients With Type 1 Diabetes
August 29th 2025

Culturally Tailored Education Empowers Patients With Type 1 Diabetes

Kennedy Ferruggia, Assistant Editor
Human fills a prior authorization form - Image credit: Maksim Shchur | stock.adobe.com
August 29th 2025

Alaska Law Implements Time Limits for Prior Authorization Decisions on Medication Coverage

Jim Ruble, PharmD, JD
Focused Female Scientist Examining Digital Data Screen in Modern Laboratory | Image Credit: sarayut | stock.adobe.com
August 29th 2025

Advancing Precision Oncology Through Pharmacy-Led Innovation

Alana Hippensteele, Lead Editor
Related Content
Advertisement
Pharmacist Spotlight: David Newman, BSPharm, RPh
August 29th 2025

Pharmacist Spotlight: David Newman, BSPharm, RPh

PT Staff David Newman, BSPharm, RPh
High-quality image of prescription opioids bottle on table symbolizing addiction crisis. Concept Addiction Crisis, Prescription Opioids, Substance Abuse, Drug Addiction Awareness - Image credit: Anastasiia | stock.adobe.com
August 29th 2025

Condition Watch: Opioid Use Disorder

Alexandra Gerlach, Associate Editor Danielle Valletti, Assistant Editor
Image credit: IbragimovN | stock.adobe.com
August 29th 2025

Products News for August 2025

Danielle Valletti, Assistant Editor
Culturally Tailored Education Empowers Patients With Type 1 Diabetes
August 29th 2025

Culturally Tailored Education Empowers Patients With Type 1 Diabetes

Kennedy Ferruggia, Assistant Editor
Human fills a prior authorization form - Image credit: Maksim Shchur | stock.adobe.com
August 29th 2025

Alaska Law Implements Time Limits for Prior Authorization Decisions on Medication Coverage

Jim Ruble, PharmD, JD
Focused Female Scientist Examining Digital Data Screen in Modern Laboratory | Image Credit: sarayut | stock.adobe.com
August 29th 2025

Advancing Precision Oncology Through Pharmacy-Led Innovation

Alana Hippensteele, Lead Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.